Form 4: Instil Bio Director George Matcham Receives Stock Options
Statement of Changes in Beneficial Ownership
Director George Matcham was granted 6,500 stock options in Instil Bio, Inc. as part of the company's equity incentive plan.
Summary
- Director George Matcham acquired 6,500 stock options to purchase common stock of Instil Bio, Inc.
- The options have an exercise price of $7.93 per share.
- The grant date for the transaction was June 11, 2026.
- The options are set to expire on June 10, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries neutral sentiment for the stock price.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon exercise.
Risks
- Vesting is contingent upon the director's continuous service to the company.
- Market price volatility may impact the future value of the granted options.
Future Outlook
The options vest in 12 substantially equal monthly installments starting July 11, 2026, with full acceleration upon death, disability, or a change in control.
Management Comments
- The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the biotechnology sector to incentivize board members and align governance with corporate performance.
Comparison to Industry Standards
- The use of 12-month vesting schedules for director equity is consistent with standard corporate governance practices for small-cap biotech firms.
- The inclusion of change-in-control acceleration clauses is standard for executive and director compensation packages.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of stock options to a director under the 2021 Equity Incentive Plan. | 06/11/2026 | Standard alignment of director incentives. |
Stakeholder Impact
- Minor dilution impact on existing shareholders.
Next Steps
- Vesting of options to commence on July 11, 2026.
Key Dates
| Date | Description |
|---|---|
| 06/11/2026 | Date of the stock option grant transaction. |
| 07/11/2026 | Commencement date for the 12 monthly vesting installments. |
| 06/10/2036 | Expiration date of the stock options. |
Keywords
Instil Bio, TIL, Form 4, Director Compensation, Stock Options, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.